Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 107185001000001111 | Carlosafine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 107185101000001112 | Carlosafine (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carlosafine | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Carlosafine 35micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) | Is a | True | Carlosafine | Inferred relationship | Existential restriction modifier | |
| Carlosafine 52.5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) | Is a | True | Carlosafine | Inferred relationship | Existential restriction modifier | |
| Carlosafine 70micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) | Is a | True | Carlosafine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR